This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB08285/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08285/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08285/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08285/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08285/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08285
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB08285 n13:DB08285
dcterms:title
(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol
adms:identifier
n6:99444756 n7:NNN n8:25190761 n9:24700216 n10:DB08285
n3:IUPAC-Name
n4:271B494C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4952-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4951-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B494E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B494F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4950-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B494A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B494B-363D-11E5-9242-09173F13E4C5 n4:271B4948-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4949-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4958-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4959-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4953-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4954-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4956-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4955-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4957-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B495E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4960-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4961-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B495D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B495C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B495F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B494D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B495A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B495B-363D-11E5-9242-09173F13E4C5